Condition
Pulmnary Hypertension
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting1
Recruiting1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07136623RecruitingPrimary
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
NCT07263958Not ApplicableNot Yet RecruitingPrimary
Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)
NCT04840251Not ApplicableWithdrawnPrimary
Investigating a Well-being Review in Pulmonary Hypertension
Showing all 3 trials